Patient characteristics at baseline
| Characteristics | Placebo group | GLP-1 4 ng · kg–1 · min–1 16-h group | GLP-1 8 ng · kg–1 · min–1 16-h group | GLP-1 4 ng · kg–1 · min–1 24-h group | GLP-1 8 ng · kg–1 · min–1 24-h group |
|---|---|---|---|---|---|
| n | 8 | 8 | 8 | 8 | 8 |
| Female/male (n) | 1/7 | 2/6 | 5/3 | 3/5 | 4/4 |
| Age range (years) | 37–69 | 43–62 | 42–66 | 50–67 | 52–68 |
| Weight range (kg) | 61–99 | 67–110 | 68–108 | 62–99 | 75–117 |
| Height range (cm) | 163–183 | 157–180 | 147–180 | 148–178 | 155–183 |
| HbA1c (%) | 9.8 ± 2.6 | 9.9 ± 1.9 | 9.5 ± 2.3 | 8.8 ± 2.2 | 10.1 ± 1.4 |
| FPG (mmol/l) | 12.7 ± 1.7 | 13.5 ± 2.5 | 14.2 ± 4.1 | 12.5 ± 3.7 | 15.9 ± 4.2 |
Data are means ± SD unless otherwise indicated.